Hostname: page-component-7c8c6479df-xxrs7 Total loading time: 0 Render date: 2024-03-28T18:04:50.682Z Has data issue: false hasContentIssue false

Comparative Trial of a New Mono-Amine Oxidase Inhibitor in Depression

Published online by Cambridge University Press:  29 January 2018

David Wheatley*
Affiliation:
325 Staines Road, Twickenham, Middlesex

Extract

The use of mono-amine oxidase inhibitors (MAOI) entails the risk of hypertensive crises with various foodstuffs and other drugs. On the other hand, the tricyclic antidepressants have a slow onset of action, and this may be a serious disadvantage in a condition like acute depression where there is always a danger of suicide. The use of an MAOI can therefore be justified if it is shown to be more effective than the tricyclic compounds.

Type
Abstract
Copyright
Copyright © The Royal College of Psychiatrists, 1970 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bailey, H. R. (1969). Personal communication.Google Scholar
Beck, A. T., Ward, Ch., Mendelson, J., Mock, J., and Erbaugh, J. (1961). ‘An inventory for measuring depression.’ Archives of General Psychiatry, 4, 53.Google Scholar
Herd, J. A. (1969). ‘A pilot study and a double-blind control trial of a new antidepressant—M and B 9302.’ Clinical Trials journal, 6, 219.Google Scholar
Wheatley, D. (1966) ‘Some problems of collating multi-participant research results.’ (Proceedings of the V Congress International Neuropsychopharmacology, 509–16). Excerpts Medica International Congress Series, 129, Washington.Google Scholar
Wheatley, D. (1969a). ‘Comparative effects of propranolol and chlordiazepoxide in anxiety states.’ British Journal of Psychiatry, 115, 1411–2.Google Scholar
Wheatley, D. (1969b). ‘A comparative trial of imipramine and phenobarbital in depressed patients seen in general practice.’ Journal of Nervous and Mental Disease, 148, 542.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.